Angiotensin converting enzyme gene polymorphism and cardiovascular disease

Clinical Science

Volumn 93, Issue 5, 1997, Pages 391-400

  Butler, R ^a   Morris, A D ^a   Struthers, A D ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Angiotensin converting enzyme gene; Cardiovascular disease; DD genotype

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CORONARY ARTERY ATHEROSCLEROSIS; DNA POLYMORPHISM; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART RIGHT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; PHENOTYPE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

EID: 0030699918     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0930391     Document Type: Review

References (74)

1. The SOLVD investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-302.
2. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992; 327: 669-77.
3. The Acute Infarction Ramipril Efficacy (AIRE) study investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993; 342: 821-8.
4. Rigat B, Hubert C, Alhenc-Gelas A, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin 1-converting-enzyme (ACE) gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-6.
5. Cambien F, Poirer O, Lecerf L, Evans A, Cambou J-P. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature (London) 1992; 359: 641-4.
6. Erdos E, Skidgel RA. The angiotensin converting enzyme. Lab Invest 1987; 56: 345-8.
7. Das M, Hartley JL, Soffers RL. Serum angiotensin-converting enzyme. Isolation and relationship to the pulmonary enzyme. J Biol Chem 1987; 252: 1316-19.
8. Shanmugan V, Sell KW, Saha BH. Mistyping ACE heterozygotes. PCR Methods Appl. 1993; 3: 120-1.
9. Lindpainter K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F. A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischaemic heart disease. N Engl J Med 1995; 332: 706-11.
10. Bloem LJ, Manatunga AK, Pratt JH. Racial differences in the relationship of an angiotensin-converting enzyme gene polymorphism to serum angiotensin-converting enzyme activity. Hypertension 1996; 27: 62-66.
11. Savage DD, Watkins LO, Grim CE, Kumanyika SK. Hypertension in black populations. In: Laragh JH, Brenner BM, eds. Hypertension, pathophysiology, diagnosis, and management. New York: Raven Press, 1990: 1837-52.
12. Mackenzie CA, Julier C, Forrester T, et al. Segregation and linkage analysis of serum angiotensin-converting enzyme levels: evidence for two quantitative-trait loci. Am J Hum Genet 1995; 57: 1426-35.
13. Mattu RK, Needham EWA, Galton DJ, Frangos E, Clark AJL, Caulfield M. A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly Heart Study. Circulation 1995; 91: 270-4.
14. Evans A, Poirer O, Kee F, Lecerf L, McCrum E. Polymorphisms of the angiotensin-converting enzyme gene in subjects who die of coronary heart disease. Q J Med 1994; 87: 211-14
15. Nakai K, Itoh C, Miura Y, et al. Deletion polymorphism of the angiotensin-converting enzyme gene is associated with serum angiotensin-converting enzyme levels and increased risk for coronary artery disease in the Japanese. Circulation 1994; 90: 2199-202.
16. Kamitani A, Rakugi H, Higaki J, Ohishi M, Shi SJ, Takami S. Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis. Hypertension 1995; 25: 950-3.
17. Zhao Y, Higashimori K, Higaki J, et al. Significance of deletion polymorphism of the angiotensin-converting enzyme gene as a risk factor for myocardial infarction in Japanese. Hypertens Res 1994; 17: 55-7.
18. Fujisawa T, Ikegami H, Shen GQ, Yamato E, Takekawa K. Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with retinopathy or nephropathy in non-insulin dependent diabetes mellitus. Diabetes Care 1995; 18: 983-5.
19. Gardemann A, Weiß T, Schwatz O, et al. Gene polymorphism but not catalytic activity of angiotensin-converting enzyme activity is associated with coronary artery disease and myocardial infarction in low risk patients. N Engl J Med 1994; 330: 1634-8.
20. Arbustini E, Grasso M, Fasani R, Klersy C, Diegoli M. Angiotensin-converting enzyme gene deletion allele is independently and strongly associated with atherosclerosis and myocardial infarction. Br Heart J 1995; 74: 584-91
21. Samani NJ, Thompson JR, O'Toole L, Channer K, Woods KL. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 1996; 94: 708-12.
22. Samani NJ, O'Toole L, Martin D, et al. Insertion/deletion polymorphisms of the angiotensin converting enzyme gene and risk of and prognosis after myocardial infarction. J Am Coll Cardiol 1996; 28: 338-44.
23. Bonn M, Berge KE, Bakken A, Erikssen J, Berg K. Insertion deletion (I/D) polymorphism at the locus for the angiotensin converting enzyme gene and myocardial infarction. Clin Genet 1993; 44: 292-7.
24. Agerholm-Larsen B, Nordestgaard BG, Steffenson R, Sorenson TIA. The angiotensin-converting enzyme gene polymorphism fails to predict coronary heart disease in a case cohort study of 7300 individuals. Circulation 1995; 92: 3849.
25. Agerholm-Larsen B, Nordestgaard BG, Steffenson R, Særenson TIA, Jensen G, Tybjërg-Hansen AT. ACE gene polymorphism: ischaemic heart disease and longevity in 10150 individuals. Circulation 1997; 95: 2358-67.
26. Friedl W, Krempler F, Paulweber B, Pickler M, Sandhofer F. A deletion polymorphism in the angiotensin-converting enzyme gene is not associated with coronary heart disease in an Austrian population. Atherosclerosis 1995; 112: 137-43.
27. Chowdhury TA, Dronsfield MJ, Jones AF, Bain SC. Angiotensin II receptor gene polymorphisms and risk of myocardial infarction. Lancet 1994; 344: 1502-3.
28. Ludwig E, Cornell PS, Anderson JL, Marshall HW, Lalonel JM, Ward RH. Angiotensin-converting enzyme gene deletion polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation 1995; 95: 2120-4.
29. Reynolds MV, Bristow MR, Bush EW, Abraham WT, Lowes BD. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 1993; 342: 1073-5.
30. Singer DRJ, Missouris CG, Jeffery S. Angiotensin-converting enzyme polymorphism: what to do about all the confusion? Circulation 1996; 94: 236-9.
31. Katsuya T, Koike G, Yee TW, et al. Association of angiotensinogen gene variant T235 with increased risk of coronary heart disease. Lancet 1995; 345: 1600-3.
32. Schuster H, Wienker TF, Stremmler U, Noll B, Steinmetz A, Luft FC. An angiotensin-converting enzyme variant is associated with acute myocardial infarction in women but not in men. Am J Cardiol 1995; 76: 601.
33. Tiret L, Kee F, Poirer O, Nicaud V, Lecerf L Deletion polymorphism of the angiotensin-converting enzyme gene associates with history of parental myocardial infarction. Lancet 1993; 341: 991-2.
34. Badenhop RF, Wang XL, Wicken DE. Angiotensin-converting enzyme genotype in children and coronary events in their grandparents. Circulation 1995; 91: 1655-8.
35. Markus HS, Barley J, Lunt R, Bland JM, Jeffery S. Angiotensin-converting enzyme gene deletion polymorphism - new risk factor for lacunar stroke but not carotid atheroma. Stroke 1995; 26: 1326-33.
36. Margalione M, Celentano E, Grandone E, Vecchione G, Cappaucci G. Deletion polymorphism of the angiotensin-converting enzyme gene in patients with a history of ischaemic stroke. Arterioscler, Thromb Vase Biol 1996; 16: 304-9.
37. Oike Y, Hata A, Ogata Y, Numata Y, Shido K, Kondo K. Angiotensin-converting enzyme as a genetic risk factor for coronary artery spasm. J Clin Invest 1995; 96: 2975-9.
38. Kuroki S, Ikeda U, Maeda Y, et al. Angiotensin-converting enzyme gene polymorphism in vasospastic angina [Abstract]. Circulation 1995 (Suppl. 1); 92: 1-96, 0458.
39. Pinto YM, Vangilst WH, Kingma JH, Schunkert H. Deletion type allele of the angiotensin-converting enzyme gene is associated with progressive ventricular dysfunction after anterior myocardial infarction. J Am Coll Cardiol 1995; 25: 1622-6.
40. Ohimichi N, Iwai N, Nakamura Y, Kinoshita M. The genotype of the angiotensin-converting enzyme gene and global left ventricular dysfunction after myocardial infarction. Am J Cardiol 1995; 76: 326-9.
41. Nakai K, Chiha N, Hosokawa S, Itoh T, Kotta K. Deletion polymorphism of the angiotensin-converting enzyme gene associates with an increased risk for late potentials in patients with myocardial infarction (Abstract). Circulation 1995; 92 (Suppl. 1): 3563.
42. Samani NJ, Martin DS, Brach M, et al. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene and risks of restenosis after coronary angioplasty. Lancet 1995; 345: 1013-16.
43. Hamon M, Bauters C, Amant C, McFadden EP, Helbecque N. Relation between the deletion polymorphism of the angiotensin-converting enzyme gene and late luminal narrowing after coronary angioplasty. Circulation 1995; 92: 296-9.
44. Ohishi M, Fujii K, Minamino T, Higaki J, Kamitani A, Rakugi H. A potent genetic risk factor for restenosis. Nature Genetics 1993; 5: 324-5.
45. Beohar N, Prather A, Qun-Tao Yu, Gerardo M, Villareal-Levy, Raizner AE. Angiotensin-converting enzyme genotype DD is a potent risk factor for coronary artery disease and restenosis post angioplasty [Abstract]. Circulation 1994; 90: 1-445, 773.
46. Harrap SB, Davidson HR, Connor JM, et al. The angiotensin-converting enzyme gene and predisposition to high blood pressure. Hypertension 1993; 21: 455-60.
47. Gu XX, Spaepen M, Guo CY, et al. Lack of association between insertion\deletion polymorphism of the angiotensin-converting enzyme gene and essential hypertension in a Belgian population. J Hum Hypertens 1994; 8:683-5.
48. Elsahat YI, Obineche EN, Lestringent GG, Frossard PM. An angiotensin-converting enzyme gene polymorphism does not correlate with hypertension in an Arab population from the United Arab Emirates. Am J Hum Genet 1995; 57: 1379.
49. Schunkert H, Hense HW, Holmer S, Stender M, Perz S, Keil U. Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. N Engl J Med 1994; 330: 1634-8.
50. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Study. N Engl J Med 1990; 322: 1561-6.
51. Sullivan JM, Van der Zwaag RV, el-Zeky F, Ramanthan KB, Mirvis DM. Left ventricular hypertrophy; effect on survival. J Am Coll Cardiol 1993; 33: 508-13.
52. Levy D, Garrison RJ, Savage DD, Kannel WB, Christiaansen JC, Castelli WP. Echocardiographic detected left ventricular hypertrophy: prevalence and risk factors: the Framingham Heart Study. Ann Intern Med 1988; 108: 7-13.
53. Iwai N, Ohimichi N, Nakamura Y, Kinoshita M. DD-genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 1994; 90: 2622-8.
54. Prasad N, OKane KPJ, Johnstone HA, et al. The relationship between blood pressure and left ventricular mass in essential hypertension is observed only in the presence of the angiotensin-converting enzyme gene deletion allele. Q J Med 1994; 87: 659-62.
55. Kupari M, Perola M, Koskinnen P, Virolainen J, Karkunnen PJ. Left ventricular size, mass and function in relation to angiotensin-converting enzyme gene polymorphism in humans. Am J Physiol 1994; 267: H1107-11.
56. Montgomery HE, Keeling PJ, Goldman JH, Humphries SE, Talmad PJ, Mckenna WJ. Lack of association between an insertion/deletion polymorphism of the angiotensin-converting enzyme gene and idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1995; 25: 1627-31.
57. Andersson B, Sylven C. The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality in idiopathic heart failure. J Am Coll Cardiol 1996; 28: 162-7.
58. Marian AJ, YU Q-T, Workman R, Greve G, Roberts R. Angiotensin-converting enzyme gene polymorphism in hypertrophic obstructive cardiomyopathy and sudden death. Lancet 1993; 342: 1085-6.
59. Yoneya K, Okamoto K, Machida M, Onozuka H, Noguchi M. Angiotensin-converting enzyme gene polymorphism in Japanese patients with hypertrophic cardiomyopathy. Am Heart J 1995; 130: 1089-93.
60. Tiret L, Bonnardeaux A, Poirer O, Ricard S, Marques-Vidal P. Synergistic effects of angiotensin-converting enzyme gene and angiotensin II type I receptor gene polymorphisms on risk of myocardial infarction. Lancet 1994; 344: 910-13.
61. Dessifulgheri P, Catalini R, Sarzini R, Sturbini S, Sirugusu N. Angiotensin-converting enzyme gene polymorphism and carotid atherosclerosis in a low risk population. J Hypertens 1995; 13: 1593-6.
62. Bonithon-Kopp C, Ducimetiere P, Touboul P-J, et al. Plasma angiotensin-converting enzyme activity and carotid wall thickening Circulation 1994; 89: 952-4.
63. Lachurie ML, Azizi M, Gugene TT, Alhencgellas F, Menard J. Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in the normotensive patient. Circulation 1995; 91: 2933-42.
64. Ueda S, Elliot HL, Morton JJ, Connell JMC. Enhanced pressor response to angiotensin I in normotensive men with deletion genotype (DD) for angiotensin-converting enzyme. Hypertension 1995; 25: 1266-9.
65. Buikema H, Pinto YM, Rooks G, Grandjean JG, Schunkert H, van Gilst WH. The deletion polymorphism of the angiotensin converting enzyme gene is related to phenotypic differences in human arteries. Eur Heart J 1996; 17: 787-94.
66. G-monomethyl L-arginine attenuates the vasodilator action of bradykinin in the forearm. Br J Pharmacol 1994; 38: 311-15.
67. Celermajer DS, Sorenson KE, Barley J, Jeffrey S, Carter N, Deanfield J. Angiotensin-converting enzyme genotype is not associated with endothelial dysfunction in subjects without other coronary risk factors. Atherosclerosis 1994; 11: 121-6.
68. Zeiher AM, Schaehinger V, Minners J, Halle M, Roschmann E. Angiotensin-converting enzyme gene deletion polymorphism is associated with impaired coronary endothelial function [Abstract]. Circulation 1995; 92: 1-96.
69. Berntorp K, Lindgarde F, Mattiasson I. Long-term effects on insulin sensitivity and sodium transport in glucose intolerant hypertensive subjects when B blockade is replaced by enalapril treatment. J Clin Invest 1993; 92: 291-8.
70. Baron AD. Hemodynamic actions of insulin. Am J Physiol 1994; 267: E187-202.
71. Ruiz J, Blanche H, Cohen N, Velho G, Cambien F, Cohen A. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary artery disease in non-insulin dependent diabetes mellitus. Proc Natl Acad Sci USA 1994; 91: 3662-5.
72. Panahloo A, Andres C, Mohamedali V, Gould MM, Talamud P. The insertion allele of the angiotensin-converting enzyme gene insertion/deletion polymorphism - a candidate gene for insulin resistance. Circulation 1995; 92: 3390-3.
73. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostatic model assessment: insulin resistance and β-cell function from fasting glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-19.
74. Katsuya T, Horiuchi M, Chen YD. Relations between deletion polymorphism of the angiotensin-converting enzyme gene and insulin resistance, glucose intolerance and dyslipidaemia. Arteriosclerosis, Thromb Vasc Biol 1995; 15: 779-82.